Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier for advanced OPTIONS screeners and volatility tools. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Concert Pharmaceutic (CNCE)

Concert Pharmaceutic (CNCE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 401,241
  • Shares Outstanding, K 47,938
  • Annual Sales, $ 32,580 K
  • Annual Income, $ -80,050 K
  • 60-Month Beta 0.52
  • Price/Sales 8,134.05
  • Price/Cash Flow N/A
  • Price/Book 3.01
Trade CNCE with:
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -3.12
  • Most Recent Earnings $-0.58 on 11/07/22
  • Latest Earnings Date 03/09/23
  • Annual Dividend & Yield 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 2 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/22
See More
  • Average Estimate -0.59
  • Number of Estimates 3
  • High Estimate -0.52
  • Low Estimate -0.66
  • Prior Year -0.95
  • Growth Rate Est. (year over year) +37.89%

Price Performance

See More
Period Period Low Period High Performance
1-Month
8.31 +0.72%
on 02/10/23
8.55 -2.11%
on 03/03/23
unch (unch)
since 02/03/23
3-Month
4.20 +99.29%
on 12/07/22
8.55 -2.11%
on 03/03/23
+3.51 (+72.22%)
since 12/02/22
52-Week
2.66 +214.66%
on 03/14/22
8.55 -2.11%
on 03/03/23
+5.59 (+201.08%)
since 03/03/22

Most Recent Stories

More News
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates CNCE, ISO, TIG

/PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws...

CNCE : 8.37 (+0.12%)
ISO : 0.7616 (+2.78%)
TIG : 6.16 (+0.16%)
Concert Pharmaceuticals Maintains Deuruxolitinib Breakthrough Therapy Designation from FDA for the Treatment of Alopecia Areata

Concert Pharmaceuticals, Inc. today announced that, after a recent review of deuruxolitinib clinical data by the U.S. Food and Drug Administration (FDA), the FDA determined that deuruxolitinib will maintain...

CNCE : 8.37 (+0.12%)
CNCE Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Concert Pharmaceuticals, Inc. Is Fair to Shareholders

Halper Sadeh LLC, an investor rights law firm, is investigating whether the sale of Concert Pharmaceuticals, Inc. (NASDAQ: CNCE) to Sun Pharmaceutical Industries Limited is fair to Concert shareholders....

CNCE : 8.37 (+0.12%)
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates CNCE, AQUA, LPTX, ALR

/PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws...

CNCE : 8.37 (+0.12%)
AQUA : 49.88 (+0.95%)
LPTX : 2.96 (-1.33%)
ALR : 1.3200 (+0.76%)
SHAREHOLDER ALERT: Weiss Law Reminds AQUA, LPTX, CNCE, and ALBO Shareholders About Its Ongoing Investigations

/PRNewswire/ -- If you own shares in any of the companies listed above and would like to discuss our investigations or have any questions concerning this...

AQUA : 49.88 (+0.95%)
LPTX : 2.96 (-1.33%)
CNCE : 8.37 (+0.12%)
ALBO : 44.15 (-0.23%)
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates ALBO, CNCE, AQUA, LPTX

/PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws...

ALBO : 44.15 (-0.23%)
CNCE : 8.37 (+0.12%)
AQUA : 49.88 (+0.95%)
LPTX : 2.96 (-1.33%)
SHAREHOLDER ALERT: Weiss Law Reminds AQUA, LPTX, CNCE, and ALBO Shareholders About Its Ongoing Investigations

/PRNewswire/ -- If you own shares in any of the companies listed above and would like to discuss our investigations or have any questions concerning this...

AQUA : 49.88 (+0.95%)
LPTX : 2.96 (-1.33%)
CNCE : 8.37 (+0.12%)
ALBO : 44.15 (-0.23%)
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates HZN, ANGN, CNCE

/PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws...

HZN : 1.7600 (unch)
ANGN : 10.0000 (+2.04%)
CNCE : 8.37 (+0.12%)
SHAREHOLDER ALERT: Weiss Law Reminds LPTX, CNCE, ALBO, and CINC Shareholders About Its Ongoing Investigations

/PRNewswire/ -- If you own shares in any of the companies listed above and would like to discuss our investigations or have any questions concerning this...

LPTX : 2.96 (-1.33%)
CNCE : 8.37 (+0.12%)
ALBO : 44.15 (-0.23%)
CINC : 29.06 (-0.48%)
Concert (CNCE) Stock Up 17% Last Week on Sun Pharma Buyout Offer

Concert Pharmaceuticals (CNCE) enters into a definitive agreement to be acquired by India-based Sun Pharmaceutical for $576 million. Stock up 17% in the previous week.

PFE : 25.39 (-0.12%)
LLY : 745.95 (-0.64%)
CNCE : 8.37 (+0.12%)
ARDX : 6.44 (-1.68%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 96% Buy with a Average short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Concert Pharmaceuticals Inc. is a biopharmaceutical company. It is focused on applying its DCE Platform (R) to create novel small molecule drugs. The Company manufactures drugs in various therapeutic areas such as hot flashes, HIV, renal hepatic, neuropathic pain, MRSA infection, and schizophrenia, multiple...

See More

Key Turning Points

3rd Resistance Point 8.70
2nd Resistance Point 8.62
1st Resistance Point 8.50
Last Price 8.37
1st Support Level 8.30
2nd Support Level 8.22
3rd Support Level 8.10

See More

52-Week High 8.55
Last Price 8.37
Fibonacci 61.8% 6.30
Fibonacci 50% 5.61
Fibonacci 38.2% 4.91
52-Week Low 2.66

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar